Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.27
-0.09-4.03%
At close: -
$2.32
0.062.50%
After Hours: Jun 20, 9:21 AM EDT
Comments
Loading...
Phio Pharma Analyst Ratings and Price Targets | NASDAQ:PHIO | Benzinga
Phio Pharmaceuticals Corp has a consensus price target of $9 based on the ratings of 2 analysts. The high is $14 issued by HC Wainwright & Co. on June 5, 2025. The low is $4 issued by HC Wainwright & Co. on April 8, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 5, 2025, April 8, 2025, and February 19, 2025, respectively. With an average price target of $7.33 between HC Wainwright & Co., there's an implied 215.87% upside for Phio Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Phio Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2025 | Buy Now | 503.03% | HC Wainwright & Co. | Joseph Pantginis40% | → $14 | Assumes | → Buy | Get Alert |
| 04/08/2025 | Buy Now | 72.29% | HC Wainwright & Co. | Vernon Bernardino49% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 72.29% | HC Wainwright & Co. | Vernon Bernardino49% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 72.29% | HC Wainwright & Co. | Vernon Bernardino49% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2024 | Buy Now | 72.29% | HC Wainwright & Co. | Vernon Bernardino49% | $6 → $4 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 158.44% | HC Wainwright & Co. | Vernon Bernardino49% | → $6 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Phio Pharma (PHIO) stock?
The latest price target for Phio Pharma (NASDAQ:PHIO) was reported by HC Wainwright & Co. on June 5, 2025. The analyst firm set a price target for $14.00 expecting PHIO to rise to within 12 months (a possible 503.03% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phio Pharma (PHIO)?
The latest analyst rating for Phio Pharma (NASDAQ:PHIO) was provided by HC Wainwright & Co., and Phio Pharma their buy rating.
When was the last upgrade for Phio Pharma (PHIO)?
There is no last upgrade for Phio Pharma
When was the last downgrade for Phio Pharma (PHIO)?
There is no last downgrade for Phio Pharma.
When is the next analyst rating going to be posted or updated for Phio Pharma (PHIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phio Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phio Pharma was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
Is the Analyst Rating Phio Pharma (PHIO) correct?
While ratings are subjective and will change, the latest Phio Pharma (PHIO) rating was a with a price target of $0.00 to $14.00. The current price Phio Pharma (PHIO) is trading at is $2.32, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
